Wednesday, December 29, 2021

When the market gets tough… The tough use →THIS←

In an uptrending market, it’s easy to look like a hero…

Buy any random stock and up… up… up it goes!

Only when the markets get tough, you can see who really knows what they’re talking about.

And there are no two finer market experts than Tom Busby and Roger Scott.

Now these two market wizards are warning that despite the new heights the market has reached this week…

There are cracks developing that you should be aware of.

And on Thursday, December 30th at 7pm Eastern, they’ll be sharing the exact strategy they use for spotting strong stocks in a weak market.

Don’t be left scrambling in the next market downturn.

Register now and learn Tom & Roger’s technique for spotting strong stocks in a weak market.

See you there!

- The DTI Team

https://www.t86trk.com/38JMMX/3HS2HZ/?uid=104&sub1=edwardlorilla1986.paxforex@blogger.com

RISK DISCLAIMER There is a very high degree of risk involved in trading. Past results are not indicative of future returns. DTI Trader and all individuals affiliated with this site assume no responsibility for your trading results. The indicators, strategies, columns, and all other features are for educational purposes only and should not be construed as advice. Information for futures trading observations are obtained from sources believed to be reliable, but we do not warrant its completeness or accuracy, or warrant any results from the use of the information. Your use of the trading observations is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness of the information. You must assess the risk of any trade with your broker and make your own independent decisions regarding any securities mentioned herein.

 


This email was sent to edwardlorilla1986.paxforex@blogger.com by DTI Trader
1555 University Blvd South | Mobile | AL | 36609

No comments:

Post a Comment

Nivolumab Appears to Boost Cure Rate in Advanced Hodgkin Lymphoma - Cancer Currents Blog

The latest from the NCI Cancer Currents blog Having trouble viewing this email? View it as a Web...